Impact of Continuous Reduction in B-Type Natriuretic Peptide Bioactivity During Hospitalization in Patients With Advanced Heart Failure

被引：0
|
作者：
Takahama, Hiroyuki
Takashio, Seiji
Hayashi, Tomohiro
Nagai, Chiaki O.
Nishikimi, Toshio
Nakagawa, Yasuaki
Amaki, Makoto
Ohara, Takahiro
Hasegawa, Takuya
Sugano, Yasuo
Kanzaki, Hideaki
Yasuda, Satoshi
Kangawa, Kenji
Minamino, Naoto
Anzai, Toshihisa
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure; Biomarkers; adult;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16248
引用
收藏
页数：2
相关论文
共 50 条
  • [31] B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues
    Yandle, Tim G.
    Richards, A. Mark
    CLINICA CHIMICA ACTA, 2015, 448 : 195 - 205
  • [32] The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide-Guided Therapy in Patients With Advanced Heart Failure
    Shah, Monica R.
    Califf, Robert M.
    Nohria, Anju
    Bhapkar, Manju
    Bowers, Margaret
    Mancini, Donna M.
    Fluzat, Mona
    Stevenson, Lynne W.
    O'Connor, Christopher M.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : 613 - 621
  • [33] Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients
    Wang, Yunhong
    Zhang, Rongcheng
    Huang, Yan
    Zhai, Mei
    Zhou, Qiong
    An, Tao
    Huang, Yuhui
    Zhao, Xuemei
    Tian, Pengchao
    Zhang, Yuhui
    Zhang, Jian
    CLINICA CHIMICA ACTA, 2019, 491 : 8 - 14
  • [34] B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure
    Larsen, Alf Inge
    Skadberg, Oyvind
    Aarsland, Torbjorn
    Kvaloy, Jan Terje
    Lindal, Sigurd
    Omland, Torbjorn
    Dickstein, Kenneth
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 136 (03) : 358 - 362
  • [35] B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure?
    Mueller, C
    Buser, P
    SWISS MEDICAL WEEKLY, 2002, 132 (43-44) : 618 - 622
  • [36] Clinical implications of normal B-type natriuretic peptide levels in patients with severe chronic heart failure
    Gao, Changzheng
    Lu, Qi
    Guo, Suxia
    Yang, Zhenyu
    Li, Kulin
    Wang, Qiang
    Wang, Ruxing
    ASIAN BIOMEDICINE, 2014, 8 (04) : 493 - 497
  • [37] B-type natriuretic peptide testing is associated with reduced cost in patients with secondary diagnosis of heart failure
    Hawkins, Robert C.
    Chung, Kenneth Ng Kwan
    CLINICA CHIMICA ACTA, 2007, 377 (1-2) : 276 - 278
  • [38] B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF
    Ambrosy, Andrew P.
    Fonarow, Gregg C.
    Albert, Nancy M.
    Curtis, Anne B.
    Heywood, J. Thomas
    Mehra, Mandeep R.
    O'Connor, Christopher M.
    Reynolds, Dwight
    Walsh, Mary N.
    Yancy, Clyde W.
    Gheorghiade, Mihai
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2012, 13 (06) : 360 - 367
  • [39] B-type natriuretic peptide is associated with post-discharge stroke in hospitalized patients with heart failure
    Hotsuki, Yu
    Sato, Yu
    Yoshihisa, Akiomi
    Watanabe, Koichiro
    Kimishima, Yusuke
    Kiko, Takatoyo
    Yokokawa, Tetsuro
    Abe, Satoshi
    Misaka, Tomofumi
    Sato, Takamasa
    Oikawa, Masayoshi
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Takeishi, Yasuchika
    ESC HEART FAILURE, 2020, 7 (05): : 2508 - 2515
  • [40] Plasma B-type Natriuretic Peptide Levels and the Risk of Death in Clinically-referred Patients With and Without Heart Failure
    York, Michelle K.
    Reynolds, Cassandra F.
    Farber-Eger, Eric
    Wells, Quinn S.
    Bachmann, Katherine N.
    Xu, Meng
    Harrell, Frank
    Gupta, Deepak K.
    Wang, Thomas J.
    CIRCULATION, 2016, 134
12345